RPS20P20

Across TCGA pan-cancer cohorts, RPS20P20 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated RPS20P20 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher RPS20P20 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPS20P20 expression acts as an unfavorable survival marker, although some lineages such as SKCM and OV show a favorable association.

LIHC, BLCA, and KICH are the cancer types where RPS20P20 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Tertile	All	0.162	0.446	.002	54	view →
BLCA	OS	Tertile	IV	0.242	0.604	<.001	42	view →
KICH	DFS	Tertile	All	0.102	0.848	.004	39	view →
THYM	DFS	Tertile	All	0.050	0.885	<.001	27	view →
PAAD	DFS	Tertile	All	0.237	0.473	.044	18	view →
KIRC	OS	Tertile	All	0.494	0.673	.002	18	view →
BRCA	OS	Tertile	III,IV	0.710	0.908	.008	18	view →
HNSC	OS	Tertile	III,IV	0.188	0.556	.027	18	view →
SARC	DFS	Tertile	All	0.195	0.601	.006	9	view →
SKCM	OS	Tertile	III,IV	0.982	0.796	.023	6	view →
OV	OS	Tertile	IV	0.799	0.565	.030	6	view →
ESCA	OS	Tertile	IV	0.264	0.713	.024	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

RPS20P20–LIHC (DFS)

Open the LIHC breakdown →